» Articles » PMID: 29928003

Elevated Galanin Receptor Type 2 Primarily Contributes to Mechanical Hypersensitivity After Median Nerve Injury

Overview
Journal PLoS One
Date 2018 Jun 22
PMID 29928003
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we investigated temporal changes in galanin receptor type 2 (GalR2) expression in NF200-, galanin-, neuropeptide Y (NPY)-, and neuronal nitric oxide synthase (nNOS)-like immunoreactive (LI) dorsal root ganglion (DRG) neurons after median nerve chronic constriction injury (CCI), and the effects of GalR2 on c-Fos expression in the cuneate nucleus (CN). Double immunofluorescence labeling methods were used to appraise changes in GalR2 expression in NF200-LI, galanin-LI, NPY-LI, and nNOS-LI DRG neurons after CCI. The von Frey assay was used to assess the efficiency of intraplantar administration of saline, M871 (a GalR2 antagonist), or AR-M1896 (a GalR2 agonist) on neuropathic signs of rats with CCI. The effects of alterations in c-Fos expression were assessed in all treatments. The percentage of GalR2-LI neurons in lesioned DRGs increased and peaked at 1 week after CCI. We further detected that percentages of GalR2-LI neurons labeled for NF200, galanin, NPY, and nNOS significantly increased following CCI. Furthermore, M871 remarkably attenuated tactile allodynia, but the sensation was slightly aggravated by AR-M1896 after CCI. Consequentially, after electrical stimulation of the CCI-treated median nerve, the number of c-Fos-LI neurons in the cuneate nucleus (CN) was significantly reduced in the M871 group, whereas it increased in the AR-M1896 group. These results suggest that activation of GalR2, probably through NPY or nitric oxide, induces c-Fos expression in the CN and transmits mechanical allodynia sensations to the thalamus.

Citing Articles

Mapping the hotspots and future trends of electrical stimulation for peripheral nerve injury: A bibliometric analysis from 2002 to 2023.

Yang S, Zhong S, Jin X, Fan G, Liao X, Yang X Int Wound J. 2023; 21(4):e14511.

PMID: 38084069 PMC: 10958100. DOI: 10.1111/iwj.14511.


A New Gal in Town: A Systematic Review of the Role of Galanin and Its Receptors in Experimental Pain.

Fonseca-Rodrigues D, Almeida A, Pinto-Ribeiro F Cells. 2022; 11(5).

PMID: 35269462 PMC: 8909084. DOI: 10.3390/cells11050839.


The activation of galanin receptor 2 plays an antinociceptive effect in nucleus accumbens of rats with neuropathic pain.

Dong Y, Li C, Zhang X, Liu Y, Yang S, Li M J Physiol Sci. 2021; 71(1):6.

PMID: 33546583 PMC: 10717428. DOI: 10.1186/s12576-021-00790-5.


The Median Nerve Injury Model in Pre-clinical Research - A Critical Review on Benefits and Limitations.

Ronchi G, Morano M, Fregnan F, Pugliese P, Crosio A, Tos P Front Cell Neurosci. 2019; 13:288.

PMID: 31316355 PMC: 6609919. DOI: 10.3389/fncel.2019.00288.

References
1.
Tsai Y, Lin C, Lue J . Characterization of the induced neuropeptide Y-like immunoreactivity in primary sensory neurons following complete median nerve transection. J Neurotrauma. 2007; 24(12):1878-88. DOI: 10.1089/neu.2007.3488. View

2.
Wang H, Tsai Y, Chen S, Lin C, Lue J . Lysophosphatidylcholine causes neuropathic pain via the increase of neuronal nitric oxide synthase in the dorsal root ganglion and cuneate nucleus. Pharmacol Biochem Behav. 2013; 106:47-56. DOI: 10.1016/j.pbb.2013.03.002. View

3.
Funck V, Fracalossi M, Vidigal A, Beijamini V . Dorsal hippocampal galanin modulates anxiety-like behaviours in rats. Brain Res. 2018; 1687:74-81. DOI: 10.1016/j.brainres.2018.02.036. View

4.
Zimmermann M . Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983; 16(2):109-110. DOI: 10.1016/0304-3959(83)90201-4. View

5.
Molander C, Hongpaisan J, Grant G . Changing pattern of c-FOS expression in spinal cord neurons after electrical stimulation of the chronically injured sciatic nerve in the rat. Neuroscience. 1992; 50(1):223-36. DOI: 10.1016/0306-4522(92)90394-h. View